USPTO serial 77342439
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Robert E. Lee, Jr.
ROBERT E. LEE, JR. ELI LILLY AND COMPANYLILLY CORPORATE CENTERINDIANAPOLIS, IN 46285-0001UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 005 | pharmaceutical and medicinal preparations for use in the treatment of rheumatoid arthritis, osteoarthritis, psoriasis, osteoporosis, human growth disorders, diabetes, and pain; prefilled drug delivery devices for use in the treatment of rheumatoid arthritis, osteoarthritis, psoriasis, osteoporosis, human growth, diabetes, and pain | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 7, 2008 | MAB1 | ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT | — |
| Feb 7, 2008 | ABN1 | ABANDONMENT - EXPRESS MAILED | — |
| Feb 6, 2008 | EXAR | TEAS EXPRESS ABANDONMENT RECEIVED | — |
| Dec 6, 2007 | NWAP | NEW APPLICATION ENTERED | — |